Recent Quotes (30 days)

You have no recent quotes
chg | %

Covalon Technologies Ltd  

(Public, CVE:COV)   Watch this stock  
Find more results for cve: cov
-0.08 (-2.01%)
Delayed:   11:58AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 3.90 - 3.99
52 week 1.45 - 4.60
Open 3.98
Vol / Avg. 3,600.00/25,247.00
Mkt cap 83.16M
P/E     -
Div/yield     -
EPS -0.05
Shares 21.41M
Beta -0.95
Inst. own     -
Dec 19, 2017
Q4 2017 Covalon Technologies Ltd Earnings Call Add to calendar
Dec 18, 2017
Q4 2017 Covalon Technologies Ltd Earnings Release - 9:30AM EST - Add to calendar
Aug 22, 2017
Q3 2017 Covalon Technologies Ltd Earnings Call
Aug 21, 2017
Q3 2017 Covalon Technologies Ltd Earnings Release

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 9.17% -46.12%
Operating margin 9.17% -44.19%
EBITD margin - -40.61%
Return on average assets 22.05% -43.84%
Return on average equity 31.45% -72.03%
CDP Score - -


1660 Tech Ave Unit 5
+1-905-5688400 (Phone)
+1-905-5685200 (Fax)

Website links


Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating technology. The collagen matrix platform is used to manufacture products that treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns. The antimicrobial silicone adhesive platform is the basis for a range of pre-surgical, post surgical and vascular access products that are designed to kill any bacteria or yeast that comes into contact with the antimicrobial silicone. The coating technology is a grafting from process, which utilizes photo-polymerization to create active grafting sites.

Officers and directors

Abe Schwartz Chairman of the Board
Brian E. Pedlar President, Chief Executive Officer, Director
Danny Brannagan Chief Financial Officer
Valerio DiTizio Chief Scientific Officer
Kim Crooks Vice President - Operations
John Hands Senior Director - Global Marketing
Elinor Caplan Director
Martin C. Bernholtz Independent Director
Ian Brindle Independent Director
Joseph Cordiano Independent Director